80
Participants
Start Date
March 15, 2024
Primary Completion Date
March 30, 2026
Study Completion Date
March 15, 2027
Nano-PSO, Pomegranate seed oil (omega-5)
"During the intervention, Nano-PSO dietary supplement will be administered to the participants in the assigned group.~Participants will be followed before and after treatment to assess the effects of Nano-PSO on cognitive status, serum concentrations of trophic factors, and other relevant parameters . This randomized, double-blind, controlled clinical trial design allows for a rigorous evaluation of the potential benefits of Nano-PSO in patients with substance use disorders. The study aims to provide valuable insights into the neuroprotective and cognitive-enhancing properties of Nano-PSO in this population."
PLACEBO
In this arm of the study the participants will receive a placebo as a control treatment . The placebo is essential in clinical trials to compare the effects of the active intervention (Nano-PSO) with those of an inert substance.
RECRUITING
Irene Guadalupe Aguilar García PhD., Guadalajara
Distribuidora Biolife SA de CV
INDUSTRY